- P-ISSN 1010-0695
- E-ISSN 2288-3339
Objectives: Epicardial fat is true visceral fat that is known to be associated with metabolic syndrome, high abdominal fat, insulin resistance, coronary artery diseases, low coronary flow reserve and subclinical atherosclerosis. Dampness-Phlegm pattern is one of the pattern diagnosis of traditional Korean medicine. Previous studies showed that Dampness-Phlegm pattern is associated with hypertension, dyslipidemia, metabolic syndrome. This study is intended to find association between Dampness-Phlegm pattern and epicardial fat thickness. Methods: This study was a community-based single center trial. Ischemic stroke patients within 30 days after their ictus were enrolled. Epicardial fat thickness was measured using transthoracic echocardiography. Other measured and obtained variables are medical history, weight, height, body mass index, fasting blood glucose, cholesterol, triglycerol, high density lipoprotein, lipid and low density lipoprotein. Results: Three hundred sixty six were enlisted, and one hundred forty were diagnosed with the Dampness-Phlegm pattern. Dampness-Phlegm pattern group had significantly thicker epicardial fat. Binary logistic regression also showed statistically significant result. Conclusions: This study showed close association between epicardial fat and Dampness-Phlegm pattern. This result suggests a clue to standardization of pattern identification.
1. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. National Clinical Practice Cardiovascular Medicine. 2005;2:536-43.
2. Rabkin SW. Epicardial fat: properties, function and relationship to obesity. Obesity Reviews. 2007;8(3):253-61.
3. Sacks HS, Fain JN, Holman B, Cheema P, Chary A, Parks F, et al. Uncoupling protein-1and related mRNAs in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. Journal of Clinical Endocrinology and Metabolism. 2009;94:3611-5.
4. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovascular Diabetology. 2006;13(5):1.
5. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460-6.
6. Iacobellis G, Willens HJ, Barbaro G, Sharma AM. Threshold values of highrisk echocardiographic epicardial fat thickness. Obesity (Silver Spring). 2008;16:887-92.
7. Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK. Echocardiographic epicardial fat thickness and coronary artery disease. Circulation Journal. 2007;71:536-9.
8. Saura D, Oliva MJ, Rodrı´guez D, Pascual-Figal DA, Hurtado JA, Pinar E, et al. Reproducibility of echocardiographic measurements of epicardial fat thickness. International Journal of Cardiology. 2010;141(3):311-3.
9. Sarin S, Wenger C, Marwaha A, Qureshi A, Go BD, Woomert CA, et al. Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Journal of Cardiology. 2008;102:767-71.
10. Sade LE, Eroglu S, Bozbasx H, Ozbic¸er S, Hayran M, Haberal A, et al. Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. Atherosclerosis. 2009;204:580-5.
11. Natale F, Tedesco MA, Mocerino R, de Simone V, Di Marco GM, Aronne L, et al. Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. European Journal of Echocardiogr. 2009;10:549-55.
12. HJ Kim, HS Bae, SU Park, SK Moon, JM Park, WS Jung. Clinical Approach to the Standardization of Oriental Medical Diagnostic Pattern identification in Stroke Patients. Evidence-Based Complementary and Alternative Medicine. 2011:7
13. World Health Organization. WHO international standard terminologies on traditional medicine in the western pacific region. 1st edition. World Health Organization. 2007:120
14. Minn IK, Kim CH, Hwang JW, Park JY, Lee SY, Choi WW, et al. The Relation of Dampness-Phlegm and Metabolic Syndrome in Acute Stroke Patients. Journal of Korean Oriental Medicine. 2009;30(1):109-19.
15. Ko SG, Jun CY, Park JH, Ko HY, Yoon YS, Choi SM, et al. Development of CRF and SOPs for the identification of risk factors of the cerebrovascular diseases in the east and west medicine. Korean Journal of Oriental Medicine. 2006;27:204–219.
16. Lee MG, Kang BK, Kim YB, Ko HY, Choi SM, Seol IC, et al. Improvement of tentative Korean standard differentiation of the symptoms and signs for stroke for clinical application. Korean Journal of Oriental Physiology & Pathology. 2007;21:347–351.
17. Kang JS, KimDH, Shin HS, et al. The Study on Relationship of Dampness-Phlegm Tongue Diagnosis to hyperlipidemia in Stroke Patients. Journal of Korean Medicine Diagnostics. 2009;13(2):24-33.